Epirubicin
Epirubicin is used in the treatment of a range of neoplastic conditions including:
− Carcinoma of the breast
− Advanced ovarian cancer
− Gastric cancer
− Small cell lung cancer
When administered intravesically, epirubicin has been shown to be beneficial in the treatment of:
− Papillary transitional cell carcinoma of the bladder
− Carcinoma-in-situ of the bladder
− Intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.
